Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2016

Open Access 01-12-2016 | Case report

Intramammary metastatic melanoma of unknown primary origin in a 58-year old patient: a case report

Authors: Zeina El-Tani, Christophe Duc, Thomas Gluecker, Olivier Cottier

Published in: Journal of Medical Case Reports | Issue 1/2016

Login to get access

Abstract

Background

Malignant melanoma metastasis to the breast is a rare disease.

Case presentation

We present the case of a 58-year-old postmenopausal Caucasian woman with metastatic malignant melanoma of unknown origin of the right breast. She presented with a palpable lump in the inferior quadrant of her right breast. The investigations concluded it was breast metastasis from a malignant melanoma of unknown origin. The treatment consisted of mastectomy and axillary lymph node dissection. Two lymph nodes were positive for tumor cells and one showed extracapsular extension. Our patient did not receive immediate adjuvant therapy. Six weeks after the surgery, our patient presented a relapse in the right axilla (a 6 × 4 cm mass) with positive internal mammary lymph nodes and a single brain metastasis. This relapse motivated an adjuvant treatment with partial regression of the disease. Currently, our patient presents multiple metastases with poor prognosis.

Conclusions

From this experience, we advocate an immediate aggressive handling of melanoma metastasis to the breast.
Literature
2.
go back to reference Ravdel L, Robinson WA, et al. Metastatic melanoma in the breast: a report of 27 cases. J Surg Oncol. 2006;94(2):101–4.CrossRefPubMed Ravdel L, Robinson WA, et al. Metastatic melanoma in the breast: a report of 27 cases. J Surg Oncol. 2006;94(2):101–4.CrossRefPubMed
3.
go back to reference Koch A, Richter-Marot A, Wissler MP, et al. Mammary metastasis of extramammary cancers: current knowledge and diagnostic difficulties. Gynecol Obstet Fertil. 2013;41:653–9.CrossRefPubMed Koch A, Richter-Marot A, Wissler MP, et al. Mammary metastasis of extramammary cancers: current knowledge and diagnostic difficulties. Gynecol Obstet Fertil. 2013;41:653–9.CrossRefPubMed
4.
go back to reference Kurul S, et al. Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature. Jpn J Clini Oncol. 2005;35:202–6.CrossRef Kurul S, et al. Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature. Jpn J Clini Oncol. 2005;35:202–6.CrossRef
5.
go back to reference Moschetta M, et al. Metastatic breast disease from cutaneous malignant melanoma. Int J Surg Rep. 2014;5(1):34–6.CrossRef Moschetta M, et al. Metastatic breast disease from cutaneous malignant melanoma. Int J Surg Rep. 2014;5(1):34–6.CrossRef
6.
go back to reference Jue KF, et al. Unusual sonographic appearance of melanoma metastases to the breast. J Ultrasound Med. 2006;25:663–6.CrossRefPubMed Jue KF, et al. Unusual sonographic appearance of melanoma metastases to the breast. J Ultrasound Med. 2006;25:663–6.CrossRefPubMed
7.
go back to reference Teodorescu EC. Sonography and mammography of primary malignant breast melanoma. Med Ultr. 2008;10(1):55–8. Teodorescu EC. Sonography and mammography of primary malignant breast melanoma. Med Ultr. 2008;10(1):55–8.
10.
go back to reference Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.CrossRefPubMedPubMedCentral Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.CrossRefPubMedPubMedCentral
11.
go back to reference Kamposioras K, Pentheroudakis G, Pectasides D, Pavlidis N. Malignant melanoma of unknown primary site: to make the long story short; a systematic review of the literature. Crit Rev Oncol Hematol. 2011;78:112–26.CrossRefPubMed Kamposioras K, Pentheroudakis G, Pectasides D, Pavlidis N. Malignant melanoma of unknown primary site: to make the long story short; a systematic review of the literature. Crit Rev Oncol Hematol. 2011;78:112–26.CrossRefPubMed
12.
go back to reference Bae J, Choi YY, Kim DS, Lee JH, et al. Metastatic melanomas of unknown prmary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2015;72:59–70.CrossRefPubMed Bae J, Choi YY, Kim DS, Lee JH, et al. Metastatic melanomas of unknown prmary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2015;72:59–70.CrossRefPubMed
13.
go back to reference De Waal AC, Aben KK, van Rossum MM, Kiemeney LA. Melanoma of unknown primary origin: a population-based study in the Netherlands. Eur J Cancer. 2013;49:676–83.CrossRefPubMed De Waal AC, Aben KK, van Rossum MM, Kiemeney LA. Melanoma of unknown primary origin: a population-based study in the Netherlands. Eur J Cancer. 2013;49:676–83.CrossRefPubMed
14.
go back to reference Burmeister BH, Henderson MA, Ainslie J, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13:589–97.CrossRefPubMed Burmeister BH, Henderson MA, Ainslie J, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13:589–97.CrossRefPubMed
15.
go back to reference Kirkwood JM, et al. A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clini Ca Re. 2004;10:1670–7.CrossRef Kirkwood JM, et al. A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clini Ca Re. 2004;10:1670–7.CrossRef
17.
go back to reference Spagnolo F, Queirolo P. Upcoming strategies for the treatment of metastatic melanoma. Arch Dermatol Res. 2012;304:177–84.CrossRefPubMed Spagnolo F, Queirolo P. Upcoming strategies for the treatment of metastatic melanoma. Arch Dermatol Res. 2012;304:177–84.CrossRefPubMed
18.
go back to reference Ribas A, et al. New challenges in endpoints for drug development in advanced melanoma. Clin Cancer Res. 2012;18:336–41.CrossRefPubMed Ribas A, et al. New challenges in endpoints for drug development in advanced melanoma. Clin Cancer Res. 2012;18:336–41.CrossRefPubMed
19.
go back to reference Chapman PB, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Eng J Med. 2011;364(26):2507–16.CrossRef Chapman PB, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Eng J Med. 2011;364(26):2507–16.CrossRef
Metadata
Title
Intramammary metastatic melanoma of unknown primary origin in a 58-year old patient: a case report
Authors
Zeina El-Tani
Christophe Duc
Thomas Gluecker
Olivier Cottier
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2016
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-016-1117-y

Other articles of this Issue 1/2016

Journal of Medical Case Reports 1/2016 Go to the issue